Inge Dierynck
9Patents
1h-index
15Co-inventors
44Inventor score
Filing activity: May 26, 2000 → Jun 21, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6958211B2 | Methods of assessing HIV integrase inhibitor therapy | Chemistry; Metallurgy | 121 | Expired |
| US7045312B2 | Method of monitoring a biological system by labeling with an apo metal binding protein | Physics | 1 | Expired |
| US7129036B1 | Reporter molecules and methods for assaying the lipidations status of a cell | Physics | 1 | Expired |
| US6800437B1 | Method of monitoring a biological system by labeling with an apo metal binding protein | Physics | 1 | Expired |
| US8546076B2 | Mutational profile in HIV-1 GAG cleavage site correlated with phenotypic drug resistance | Physics | 0 | Active |
| US8202887B2 | 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors | Human Necessities | 0 | Active |
| US7189505B2 | Methods of assessing HIV integrase inhibitor therapy | Chemistry; Metallurgy | 0 | Expired |
| US8318779B2 | Lysine related derivatives as HIV aspartyl protease inhibitors | Human Necessities | 0 | Active |
| US7863428B2 | Fluorogenic enzyme substrates and methods of preparation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.